OTCM
RVVQF
Market cap1kUSD
Nov 03, Last price
0.00USD
Name
Ravenquest Biomed Inc
Chart & performance
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
238.45%
Revenues
1m
+1,018.82%
Net income
-30m
L+822.99%
CFO
-11m
L+342.23%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
RavenQuest BioMed Inc. operates primarily within the cannabis industry. Its core activities include the cultivation of cannabis, offering management and consulting solutions, and conducting specialized research and development. The company structures its operations into two distinct areas: a consulting division and a segment dedicated to the growth and sale of medical cannabis. Its products are available under the brand names Lore Cannabis and Bloomera. The entity, originally known as Ravencrest Resources Inc., rebranded to RavenQuest BioMed Inc. in September 2017. Founded in 1987, its corporate headquarters are situated in Vancouver, Canada.
Key people
George Robinson
President, Chief Executive Officer, Director · since 2017
Simerjeet Kaur
Plant Breeder and Geneticist
Benilda Sable
Quality Assurance
Marla Ritchie
Corporate Secretary
Usama Chaudhry
Interim Chief Financial Officer, Director · since 2019
Jatinder Dhaliwal
Director · since 2019
Cassidy McCord
Director · since 2019
Mark Percival
Director · since 2019
Legal address
C/O Cassels Brock & Blackwell LLP
Suite 2200, HSBC Building
885 West Georgia Street
Vancouver, BC V6C 3E8
CA
Suite 2200, HSBC Building
885 West Georgia Street
Vancouver, BC V6C 3E8
CA
Headquarters
Suite 780 – 580 Hornby Street
Vancouver, BC V6C 3B6
CA
Vancouver, BC V6C 3B6
CA
Previous name
RAVENCREST RESOURCES INC.
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY |
|---|---|---|---|
| 2018‑10 | 2017‑10 | 2016‑10 | |
| Income | |||
Revenues | |||
Cost of revenue | |||
Unusual Expense (Income) | |||
NOPBT | |||
NOPBT Margin | |||
Operating Taxes | |||
Tax Rate | |||
NOPAT | |||
Net income | |||
Dividends | |||
Dividend yield | |||
Proceeds from repurchase of equity | |||
BB yield | |||
| Debt | |||
Debt current | |||
Long-term debt | |||
Deferred revenue | |||
Other long-term liabilities | |||
Net debt | |||
| Cash flow | |||
Cash from operating activities | |||
CAPEX | |||
Cash from investing activities | |||
Cash from financing activities | |||
FCF | |||
| Balance | |||
Cash | |||
Long term investments | |||
Excess cash | |||
Stockholders' equity | |||
Invested Capital | |||
ROIC | |||
ROCE | |||
| EV | |||
Common stock shares outstanding | |||
Price | |||
Market cap | |||
EV | |||
EBITDA | |||
EV/EBITDA | |||
Interest | |||
Interest/NOPBT |